Effect of Pulsatile Hormone Administration on Insulin Action

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-75
SponsorPennington Biomedical Research Center

About this trial

In humans, insulin is secreted in pulses from the pancreatic beta-cells, and these oscillations help to maintain fasting plasma glucose levels within a narrow normal range. Given the fluctuations in insulin concentrations, oscillations enhance precision of control. The hyperinsulinemic euglycemic clamp test (clamp) involves a continuous infusion of insulin and is the gold standard for measuring insulin sensitivity. In this study, insulin sensitivity measured using the standard clamp will be compared with a clamp in which the same total amount of insulin as the standard clamp is infused every five minutes instead of continuously.

Eligibility criteria

Qualifiers

Completion of the Motivate Study (NCT05649176)

Disqualifiers

Non-completion of the end-of-study hyperinsulinemic euglycemic clamp test of the Motivate study

Trial design

Treatments tested in this trial

  • Continuous Insulin administration during hyperinsulinemic euglycemic clamp test
  • Pulsatile Insulin administration during hyperinsulinemic euglycemic clamp test

Treatment groups

12 Participants
are divided into 2 treatment groups

Locations

1
Pennington Biomedical Research Center70808, Baton RougeLouisiana, United States

Sponsors and collaborators

Pennington Biomedical Research Center

Lead sponsor